BrightSpring Health price target raised to $43 from $39 at Wells Fargo

Wells Fargo raised the firm’s price target on BrightSpring Health (BTSG) to $43 from $39 and keeps an Overweight rating on the shares. For managed care organizations, the firm is most constructive on Medicare Advantage with uncertainty high for Medicaid/Exchanges. Wells sees a more difficult backdrop for hospitals in 2026 as post-COVID tailwinds wane and legislative risks near. Distributor debate remains revisions vs. multiples.